Search

AMP leads the UK launch of Cellenis PRP DermaFiller

Written by...

Aesthetic Medical Partnership (AMP) has announced the UK launch of Cellenis PRP DermaFiller, a fully autologous regenerative volumiser.

Developed by ESTAR, the system is designed to process small blood volumes while removing granulocytes and erythrocytes to optimise the PRP’s biological profile. This approach ensures a higher platelet concentration, enhancing regenerative outcomes, according to the company.

Following the AMP launch event in October, the new product is now available to patients, with practitioners trained and ongoing training underway.

AMP co-founder and director Martyn Roe said, “We are delighted to be building on the firm foundations Medira have already laid in the UK market. We look forward to adding Cellenis customers to our growing list of AMP partners.”

Share this article: